User profiles for Daniele Prati
Daniele PratiDirettore, Dipartimento di Medicina Trasfusionale e di Ematologia, Fondazione IRCCS Ca' … Verified email at policlinico.mi.it Cited by 16648 |
Updated definitions of healthy ranges for serum alanine aminotransferase levels
D Prati, E Taioli, A Zanella, ED Torre… - Annals of internal …, 2002 - acpjournals.org
Background: Serum alanine aminotransferase (ALT) activity, the variable most commonly
measured to assess hepatic disease, fails to identify many patients with hepatic injury. Current …
measured to assess hepatic disease, fails to identify many patients with hepatic injury. Current …
Statements from the Taormina expert meeting on occult hepatitis B virus infection
Occult hepatitis B virus (HBV) infection is one of the most challenging topics in the field of
viral hepatitis with its virological and clinical relevance being debated for more than 30 years. …
viral hepatitis with its virological and clinical relevance being debated for more than 30 years. …
[PDF][PDF] Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women
D Conte, M Fraquelli, D Prati, A Colucci, E Minola - Hepatology, 2000 - Wiley Online Library
The prevalence and natural course of chronic hepatitis C virus (HCV) infection was
evaluated in 15,250 consecutive pregnant women. The rate of HCV vertical and perinatal …
evaluated in 15,250 consecutive pregnant women. The rate of HCV vertical and perinatal …
[HTML][HTML] Effects of the COVID-19 pandemic on supply and use of blood for transfusion
The COVID-19 pandemic has major implications for blood transfusion. There are uncertain
patterns of demand, and transfusion institutions need to plan for reductions in donations and …
patterns of demand, and transfusion institutions need to plan for reductions in donations and …
[HTML][HTML] International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
Primary biliary cirrhosis (PBC) is a classical autoimmune liver disease for which effective
immunomodulatory therapy is lacking. Here we perform meta-analyses of discovery data sets …
immunomodulatory therapy is lacking. Here we perform meta-analyses of discovery data sets …
[HTML][HTML] Update of the statements on biology and clinical impact of occult hepatitis B virus infection
In October 2018 a large number of international experts with complementary expertise
came together in Taormina to participate in a workshop on occult hepatitis B virus infection (OBI). …
came together in Taormina to participate in a workshop on occult hepatitis B virus infection (OBI). …
Integrated longitudinal immunophenotypic, transcriptional, and repertoire analyses delineate immune responses in patients with COVID-19
To understand how a protective immune response against SARS-CoV-2 develops over time,
we integrated phenotypic, transcriptional, and repertoire analyses on PBMCs from patients …
we integrated phenotypic, transcriptional, and repertoire analyses on PBMCs from patients …
[HTML][HTML] Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
Background & Aims Hepatocellular carcinoma (HCC) risk stratification in individuals with
dysmetabolism is a major unmet need. Genetic predisposition contributes to non-alcoholic fatty …
dysmetabolism is a major unmet need. Genetic predisposition contributes to non-alcoholic fatty …
[HTML][HTML] Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆
Background & Aims Genetic factors associated with non-alcoholic fatty liver disease (NAFLD)
remain incompletely understood. To date, most genome-wide association studies (GWASs…
remain incompletely understood. To date, most genome-wide association studies (GWASs…
Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review
D Prati - Journal of hepatology, 2006 - Elsevier
Hepatitis C virus (HCV) is a leading cause of chronic blood-borne infection and chronic liver
disease. The global epidemic of HCV infection emerged in the second half of the 20th …
disease. The global epidemic of HCV infection emerged in the second half of the 20th …